Trabectedin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1165 publications

Drugging the undruggable: early phase trial shows trabectedin and low-dose irinotecan downregulate EWSR1::FLI1 and has clinical activity in advanced Ewing sarcoma.

Drugging the undruggable: early phase trial shows trabectedin and low-dose irinotecan downregulate EWSR1::FLI1 and has clinical activity in advanced Ewing sarcoma.

Journal: Trends in cancer

Published: June 15, 2026

Targeting IGF2BP3 in Cancer: From Molecular Structure and Biology to Early Drug Discovery.

Targeting IGF2BP3 in Cancer: From Molecular Structure and Biology to Early Drug Discovery.

Journal: International journal of molecular sciences

Published: June 05, 2026

EVDI++: Event-based Video Deblurring and Interpolation via Self-Supervised Learning.

EVDI++: Event-based Video Deblurring and Interpolation via Self-Supervised Learning.

Journal: IEEE transactions on pattern analysis and machine intelligence

Published: May 29, 2026

Antitumor activity of novel transcriptional inhibitors ecubectedin and PM54 in soft tissue sarcoma patient-derived xenografts.

Antitumor activity of novel transcriptional inhibitors ecubectedin and PM54 in soft tissue sarcoma patient-derived xenografts.

Journal: Cancer research communications

Published: May 25, 2026

The Evolving Landscape of Systemic Therapy for Liposarcoma.

The Evolving Landscape of Systemic Therapy for Liposarcoma.

Journal: Cancers

Published: April 21, 2026

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Journal: Oncology and therapy

Published: April 21, 2026

Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials.

Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials.

Journal: Cancers

Published: March 25, 2026

Trabectedin-Associated Myocardial Infarction With Nonobstructive Coronary Arteries.

Trabectedin-Associated Myocardial Infarction With Nonobstructive Coronary Arteries.

Journal: JACC. Case reports

Published: March 25, 2026

Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.

Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 03, 2026

Prognostic value of nutritional and inflammation-based scores in advanced soft tissue sarcoma treated with trabectedin: a multicenter study.

Prognostic value of nutritional and inflammation-based scores in advanced soft tissue sarcoma treated with trabectedin: a multicenter study.

Journal: Frontiers in oncology

Published: February 28, 2026

Crystal Structure of Trabectedin-DNA Complex.

Crystal Structure of Trabectedin-DNA Complex.

Journal: Journal of molecular biology

Published: February 25, 2026

Impact of a Rapid Weaning Protocol on the Incidence of External Ventricular Drain-Related Infections in Patients With Aneurysmal Subarachnoid Hemorrhage: A Retrospective Before-After Comparative Study.

Impact of a Rapid Weaning Protocol on the Incidence of External Ventricular Drain-Related Infections in Patients With Aneurysmal Subarachnoid Hemorrhage: A Retrospective Before-After Comparative Study.

Journal: Operative neurosurgery (Hagerstown, Md.)

Published: February 19, 2026

Showing 1-12 of 1,165

Last Updated: 09/26/2026